Press release

ROBO Global Healthcare Technology ETF (HTEC) Debuts on NYSE

Sponsored by Businesswire

ROBO Global, the creators of the first-ever index to track the global robotics, automation and AI (RAAI) value chain, is bringing another innovative index to market with the debut of the ROBO Global® Healthcare Technology & Innovation Index. The investment thesis tracked by this index will be available to investors starting today in a new-to-market exchange traded fund, the ROBO Global® Healthcare Technology and Innovation ETF (NYSE: HTEC).

ROBO Global has once again partnered with Exchange Traded Concepts (ETC) to launch HTEC, following the team’s introduction of the ROBO Global® Robotics & Automation Index ETF (NYSE Arca: ROBO) in 2013, which has cumulatively returned 58.87%* since inception.

“By and large, the healthcare industry appears to be primed for massive market growth thanks to the implementation of advanced technologies like robotics and AI,” said Travis Briggs, CEO of ROBO Global U.S. “The healthcare AI market is expected to grow at a compound annual growth rate between 47-50% by 2025, a value of $36 billion**. We’re privileged to continue leveraging the knowledge of our distinguished advisory board members, who are on the front lines of industry innovation, to bring the growth potential of these technologies directly to investors.”

The ROBO Global® Healthcare Technology & Innovation Index provides unique, comprehensive global exposure to the technology transforming healthcare as we know it. This index was expertly crafted using the same recipe that has brought global success to the ROBO Global Robotics & Automation Index: cutting-edge research and intelligence from distinguished industry experts in robotics and AI.

The 85 index constituents include companies in nine subsectors, including precision medicine and medical instruments. In an attempt to capture the growth of rapidly evolving healthcare technology companies, the index rebalances on a quarterly basis and follows a modified factor weighting scheme.

“When developing the ROBO Global® Healthcare Technology & Innovation Index, we put an emphasis on analyzing companies making the most dramatic impact on the healthcare sector of today and tomorrow,” said Jeremie Capron, Director of Research at ROBO Global. “Simply put, we are zeroed in on the disruptors rather than the disrupted.”

For more information on ROBO Global’s approach to investing in innovation, please visit:

About ROBO Global

ROBO Global is an index, advisory, and research company wholly focused on helping investors capture the unique opportunities of fast-growing robotics, artificial intelligence, and healthcare technology companies around the world. With the expertise of our leadership team and strategic advisors from the industry, we help investors capture the growth and return opportunities presented by innovation across industries, from healthcare to industrials to consumer products. Our indices are used by a variety of investment vehicles listed on multiple exchanges around the world. We are present in Dallas, San Francisco, New York and London.

*Data as of 6/21/19

**Source: MarketsandMarkets Research

ROBO Annualized Performance as of 3/31/19 is as follows (NAV/MKT Price): 1 year -6.69%/-7.03%; 5 year 7.34%/7.57%; since inception 8.56%/8.62%. Inception date is 10/21/13. Performance data quoted represents past performance and is no guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor`s shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the original cost. For performance data current to the most recent month end, please call 1-855-456-7626 or visit Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Market price returns are based upon the midpoint of the bid/ask spread at the close of the exchange and does not represent the returns an investor would receive if shares were trade at other times. Brokerage commissions will reduce returns. NAVs are calculated using prices as of 4:00 PM Eastern Time.

Performance of ROBO does not reflect performance of HTEC. Investing involves risk, including the possible loss of principal. International investments may also involve risk from unfavorable fluctuations in currency values, differences in generally accepted accounting principles, and from economic or political instability. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Narrowly focused investments and investments in smaller companies typically exhibit higher volatility. There is no guarantee the fund will achieve its stated objective.

Carefully consider the Fund’s investment objectives, risk factors, charges and expenses before investing. This and additional information can be found on the Funds’ full or summary prospectus, which may be obtained at Read the prospectus carefully before investing.

Exchange Traded Concepts, LLC serves as the investment advisor, and Vident Investment Advisory, LLC serves as a sub advisor to the Fund. The Funds are distributed by SEIInvestments Distribution Co. (SIDCO), which is not affiliated with Exchange Traded Concepts, LLC or any of its affiliates.